PRECIPIO, INC. Gain (Loss) on Extinguishment of Debt
PRECIPIO, INC. (PRPO) reported Gain (Loss) on Extinguishment of Debt of $794.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-30
- PRECIPIO, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was $0.00.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-09-30 was $0.00.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-06-30 was $0.00.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for the quarter ending 2021-03-31 was $794.00K.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for fiscal 2021 was $794.00K.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for fiscal 2020 was -$1.23M.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for fiscal 2019 was -$20.00K, a 105.32% decline from fiscal 2018.
- PRECIPIO, INC. gain (loss) on extinguishment of debt for fiscal 2018 was $376.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $794.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $794.00K 10-Q · filed 2022-11-10 | $794.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $794.00K 10-Q · filed 2022-08-11 | $794.00K derived: sum of 3 quarters · filed 2022-08-11 | $794.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $794.00K 10-Q · filed 2022-05-11 | $794.00K derived: sum of 2 quarters · filed 2022-05-11 | $794.00K derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | -$1.23M 10-K · filed 2021-03-29 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$1.23M 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | -$1.23M 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | -$20.00K 10-K · filed 2021-03-29 | |||
| 2018-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $376.00K derived: sum of 2 quarters · filed 2020-03-27 | $376.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $284.00K 10-Q · filed 2019-11-13 | $284.00K 10-Q · filed 2019-11-13 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16 | -$1.34M derived: sum of 2 quarters · filed 2019-04-16 | -$1.39M derived: sum of 3 quarters · filed 2019-04-16 | -$1.39M 10-K · filed 2019-04-16 |
| 2017-09-30 | -$1.34M 10-Q · filed 2018-11-19 | -$1.39M derived: sum of 2 quarters · filed 2018-11-19 | -$1.39M 10-Q · filed 2018-11-19 | |
| 2017-06-30 | -$53.00K 10-Q · filed 2018-08-16 | -$53.00K 10-Q · filed 2018-08-16 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-20 | $0.00 derived: sum of 2 quarters · filed 2017-11-20 | $0.00 10-Q · filed 2017-11-20 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-22 | $0.00 10-Q · filed 2017-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |